semaglutide weight loss surprise People using popular weight-loss drugs like ozempic are being warned to be on the look-out for an unexpected side effect. Dentists say those who use the glp-1 medications could end up with increased Post-holiday reset, made simple ✨

Patients seeking a dual-action approach sometimes ask about Mounjaro KwikPen, which targets both GLP-1 and GIP receptors for potentially greater weight reduction in eligible patients

This commonly includes lifelong treatment for pernicious anaemia, managing severe B12 deficiency with neurological symptoms to prevent further damage, and for individuals post-gastric surgery due to impaired absorption

J Gerontol A Biol Sci Med Sci 2013

Do not use syringes larger than 1mL for the actual injection, as the larger barrel makes precise measurements difficult

Semaglutide (Wegovy, Ozempic) aims at one receptor (GLP-1), while tirzepatide (Zepbound, Mounjaro) homes in on two (GLP-1 and GIP)